Every year, lung cancer kills more than 100,000 people in the United States. Smoking is the leading risk factor for lung ...

GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity for their effectiveness in treating type 2 diabetes and obesity, but ...

The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart ...

Understanding how drug delivery systems distribute in vivo remains a major challenge in developing nanomedicines. Especially in the lung, the complex and dynamic microenvironment often limits the ...

A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval, positioning the biologic medicine to reach ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...

Certain medications, including those sold over-the-counter, can worsen inflammatory bowel disease symptoms. Get expert advice on which ones to avoid.

High blood pressure affects nearly 1 in 8 people worldwide, and its impact goes far beyond a number on a blood pressure monitor. It can quietly damage the heart, kidneys and brain, making it one of ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...